These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18097775)

  • 1. Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis.
    Veldman C; Feliciani C
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):313-20. PubMed ID: 18097775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pemphigus, a pathomechanism of acantholysis.
    Furue M; Kadono T
    Australas J Dermatol; 2017 Aug; 58(3):171-173. PubMed ID: 28211055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
    Cirillo N; Gombos F; Lanza A
    J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro pathogenicity assay for anti-desmoglein autoantibodies in pemphigus.
    Ishii K; Amagai M
    Methods Mol Biol; 2013; 961():219-25. PubMed ID: 23325646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides Targeting the Desmoglein 3 Adhesive Interface Prevent Autoantibody-induced Acantholysis in Pemphigus.
    Heupel WM; Müller T; Efthymiadis A; Schmidt E; Drenckhahn D; Waschke J
    J Biol Chem; 2009 Mar; 284(13):8589-95. PubMed ID: 19164289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus foliaceus.
    Dasher D; Rubenstein D; Diaz LA
    Curr Dir Autoimmun; 2008; 10():182-94. PubMed ID: 18460886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the pathogenicity of anti-desmoglein antibodies of pemphigus vulgaris patients using human organ culture assay.
    Saleh AM; El-Samanoudy SI; Rashed LA; Saleh MA
    Arch Dermatol Res; 2020 May; 312(4):289-294. PubMed ID: 31587106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris.
    Chernyavsky A; Amber KT; Agnoletti AF; Wang C; Grando SA
    J Biol Chem; 2019 Mar; 294(12):4520-4528. PubMed ID: 30692201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
    Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
    J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis is not required for acantholysis in pemphigus vulgaris.
    Schmidt E; Gutberlet J; Siegmund D; Berg D; Wajant H; Waschke J
    Am J Physiol Cell Physiol; 2009 Jan; 296(1):C162-72. PubMed ID: 18987254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of synergy of autoantibodies to M3 muscarinic acetylcholine receptor and secretory pathway Ca
    Chernyavsky A; Patel KG; Grando SA
    Int Immunopharmacol; 2020 Mar; 80():106149. PubMed ID: 31958740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.
    Heupel WM; Zillikens D; Drenckhahn D; Waschke J
    J Immunol; 2008 Aug; 181(3):1825-34. PubMed ID: 18641320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective.
    van der Wier G; Jonkman MF; Pas HH; Diercks GF
    Br J Dermatol; 2012 Dec; 167(6):1265-71. PubMed ID: 22835262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"?
    Amagai M; Ahmed AR; Kitajima Y; Bystryn JC; Milner Y; Gniadecki R; Hertl M; Pincelli C; Kurzen H; Fridkis-Hareli M; Aoyama Y; Frusić-Zlotkin M; Müller E; David M; Mimouni D; Vind-Kezunovic D; Michel B; Mahoney M; Grando S
    Exp Dermatol; 2006 Oct; 15(10):815-31. PubMed ID: 16984264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion.
    Walter E; Vielmuth F; Wanuske MT; Seifert M; Pollmann R; Eming R; Waschke J
    Front Immunol; 2019; 10():1128. PubMed ID: 31178865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.
    Chernyavsky AI; Arredondo J; Kitajima Y; Sato-Nagai M; Grando SA
    J Biol Chem; 2007 May; 282(18):13804-12. PubMed ID: 17344213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus: Current and Future Therapeutic Strategies.
    Didona D; Maglie R; Eming R; Hertl M
    Front Immunol; 2019; 10():1418. PubMed ID: 31293582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.